Return to Article Details
COMBINATION THERAPY WITH NOVEL HORMONE AGENT AND PARP INHIBITORS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: INITIAL EXPERIENCE AT THE UROLOGY DEPARTMENT, CHO RAY HOSPITAL
Download
Download PDF